The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10

The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis

(2014) T. M. Woodruff et al.   JOURNAL OF IMMUNOLOGY

Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis

(2012) Dale Pavlovski et al.   FASEB JOURNAL

Regulator of Calcineurin 1 (Rcan1) Is Required for the Development of Pulmonary Eosinophilia in Allergic Inflammation in Mice

(2011) Yong Jun Yang et al.   AMERICAN JOURNAL OF PATHOLOGY

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Eculizumab

(2011) Kate McKeage   DRUGS

Inhibiting the C5–C5a receptor axis

(2011) Trent M. Woodruff et al.   MOLECULAR IMMUNOLOGY

Unknown

(2011) Christian Ehrnthaller et al.   MOLECULAR MEDICINE

Adverse effects of biologics used for treating IBD

(2010) Andreas Stallmach et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis

(2010) H. F. Langer et al.   BLOOD

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

In Vitro-Derived Alternatively Activated Macrophages Reduce Colonic Inflammation in Mice

(2010) Meaghan M. Hunter et al.   GASTROENTEROLOGY

Association of genetic variants of mannan-binding (MBL) lectin-2 gene, MBL levels and function in ulcerative colitis and Crohn’s disease

(2010) G Sivaram et al.   Innate Immunity

Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis

(2010) Guojiang Chen et al.   LABORATORY INVESTIGATION

Arginase: an emerging key player in the mammalian immune system

(2009) Markus Munder   BRITISH JOURNAL OF PHARMACOLOGY

Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease

(2009) Kay Johswich et al.   INFLAMMATORY BOWEL DISEASES

Role of TNF receptors, TNFR1 and TNFR2, in dextran sodium sulfate-induced colitis

(2009) RoseMarie Stillie et al.   INFLAMMATORY BOWEL DISEASES

Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice

(2009) Josep Mañé et al.   INFLAMMATORY BOWEL DISEASES

Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease

(2009) M. I. Fonseca et al.   JOURNAL OF IMMUNOLOGY

Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced Colitis

(2009) Yutao Yan et al.   PLoS One

Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease

(2008) Silvia Melgar et al.   INTERNATIONAL IMMUNOPHARMACOLOGY